Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Approvals Action
Shakeup for insulin

Posted 19 October 2020 

The TGA has approved the first biosimilar of Novo Nordisk's diabetes treatment insulin aspart along with three generic versions of drugs that already appear on the PBS.

The first insulin aspart biosimilar sponsored by Sanofi is approved in cartridge and pre-filled pen configurations under brand name Truvelog. Read more here.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Special Report
Aust Covid Vaccine Tracker
UPDATES: UNICEF stockpiling one billion syringes
Approvals Action
Shakeup for insulin
New biosim plus hypertension and herpes generics
Top of the Hill
Avoiding the Emperor's mistake
Not everyone is convinced about industry's budget win